Frontlight ResearchEarly access
TerminatedNo phase
Myocardial Infarction Triggers and Onset in Jordan Study 2
Key facts
- Who runs it
- Jordan Collaborating Cardiology Group
- Where
- Jordan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 1,000 people enrolled
- Started
- 1 Oct 2023
- Ended
- 25 Dec 2023
- Type of study
- Observational
- Record updated
- 29 December 2023
- Why it stopped
- Protocol not adopted by study teams
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age 18 years and above
- Documented acute ST elevation myocardial infarction
- Willing to sign an informed consent
- Available contact numbers for a 3-year follow up
Who cannot take part
- Unwilling to sign an informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A previous study (MINTOR 1) found that 43% of ST elevation myocardial infarction (STEMI) patients in Jordan had a triggering events. Fifteen years later, with changing demographics and in the post covid-19 time, we believe that triggered acute myocardial infarction might have changed in incidence and nature of the triggering events.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Myocardial Infarction Triggers and Onset in Jordan Study (MINTOR) 2
- Record updated
- 29 December 2023